
Comtripsy 6.14mg/20mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Tipiracil (6.14mg) + Trifluridine (20mg)
Overview Comtripsy 6.14mg/20mg Tablet
OncoComb 6.14mg/20mg tablets combine two cancer-fighting agents, effectively managing metastatic colorectal cancer. This medication inhibits or reduces the proliferation of cancerous cells. For optimal absorption, take OncoComb 6.14mg/20mg with food, consistently at the same time daily. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, potentially taking weeks or months; discontinue only under your doctor's guidance. Common side effects include low blood cell counts (anemia, neutropenia, thrombocytopenia), fatigue, nausea, appetite loss, diarrhea, vomiting, and fever. Report any concerning side effects to your physician. Regular blood tests monitoring blood cell levels and liver function are crucial. Inform your healthcare provider of all other medications you're taking due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Uses of Comtripsy 6.14mg/20mg Tablet
Colorectal cancer
Major Benefits of Comtripsy 6.14mg/20mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Comtripsy 6.14mg/20mg tablets with a meal.
Common Side effects of Comtripsy 6.14mg/20mg Tablet:
- Anemia (low number of red blood cells)
- Decreased white blood cell count (neutrophils)
- Fatigue
- Nausea
- Low blood platelets
- Decreased appetite
- Diarrhea
- Fever
- Vomiting
How to use Comtripsy 6.14mg/20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Comtripsy 6.14mg/20mg tablets should be administered with a meal.
How Comtripsy 6.14mg/20mg Tablet works:
Each Comtripsy 6.14mg/20mg tablet unites two anti-neoplastic agents. Trifluridine inhibits DNA replication, thereby halting cancer cell proliferation. Concurrently, tipiracil extends trifluridine's duration of action within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Comtripsy 6.14mg/20mg tablets lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Comtripsy 6.14mg/20mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingCAUTION
The use of Comtripsy 6.14mg/20mg tablets necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
The impact of Comtripsy 6.14mg/20mg Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Comtripsy 6.14mg/20mg tablets are suitable for patients with impaired renal function. No dosage modification is needed for Comtripsy 6.14mg/20mg tablets in this patient population.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely take Comtripsy 6.14mg/20mg tablets without requiring any dosage modification.
What if you forget to take Comtripsy 6.14mg/20mg Tablet :
Should you forget a Comtripsy 6.14mg/20mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Comtripsy 6.14mg/20mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
